Article
The influence of the p53 codon 72 polymorphism on ovarian carcinogenesis and prognosis.
Cancer gene therapy - 1 Jan 2000
Buller R E, Sood A, Fullenkamp C, Sorosky J, Powills K, Anderson B
Abstract excerpt
The frequency of dysfunction of the p53 tumor suppressor gene in cancer has made the concept of gene replacement therapy with wild-type p53 an attractive strategy. Codon 72 of the p53 gene is highly polymorphic with a reported arginine/proline allelotype frequency of 0.65/0.35 for Caucasians and a reversal of this ratio in African-Americans. Ovarian cancer is more common and less aggressive in Caucasians. The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
